The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Functional Role of Type I and Type II Interferons in Antiviral Defense
Open accessAbstract
Mice lacking the known subunit of the type I interferon (IFN) receptor were completely unresponsive to type I IFNs, suggesting that this receptor chain is essential for type I IFN-mediated signal transduction. These mice showed no overt anomalies but were unable to cope with viral infections, despite otherwise normal immune responses. Comparison of mice lacking either type I or type II IFN receptors showed that, at least in response to some viruses, both IFN systems are essential for antiviral defense and are functionally nonredundant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fort, P., Marty, L., Piechaczyk, M., Sabrouty, S. E., Dani, C., Jeanteur, P., & Blanchard, J. M. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.5.1431 · Cited by 2,099
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein
Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.-P., DeArmond, S. J., Prusiner, S. B., Aguet, M., & Weissmann, C. (1992) · Nature · doi:10.1038/356577a0 · Cited by 1,655
Self-citationImmune Response in Mice that Lack the Interferon-γ Receptor
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., & Aguet, M. (1993) · Science · doi:10.1126/science.8456301 · Cited by 1,548
Self-citationMiyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T., & Taniguchi, T. (1988) · Cell · doi:10.1016/s0092-8674(88)91307-4 · Cited by 978
Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia
Quesada, J. R., Reuben, J., Manning, J. T., Hersh, E. M., & Gutterman, J. U. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401053100104 · Cited by 820
Cytokine therapeutics: lessons from interferonalpha.
Gutterman, J. U. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1198 · Cited by 703
Talpaz, M., Kantarjian, H. M., McCredie, K., Trujillo, J. M., Keating, M. J., & Gutterman, J. U. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604243141701 · Cited by 647
Uzé, G., Lutfalla, G., & Gresser, I. (1990) · Cell · doi:10.1016/0092-8674(90)90738-z · Cited by 574
Structure of the human immune interferon gene
Gray, P. W., & Goeddel, D. V. (1982) · Nature · doi:10.1038/298859a0 · Cited by 508
Cited by
Items 201–268 of 268
Antiviral response by natural killer cells throughTRAIL gene induction by IFN-α/β
Sato, K., Hida, S., Takayanagi, H., Yokochi, T., Kayagaki, N., Takeda, K., Yagita, H., Okumura, K., Tanaka, N., Taniguchi, T., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3138::aid-immu3138>3.0.co;2-b · Cited by 271
Crotta, S., Davidson, S., Mahlakoiv, T., Desmet, C. J., Buckwalter, M. R., Albert, M. L., Staeheli, P., & Wack, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003773 · Cited by 269
IFN‐α/β enhances BCR‐dependent B cell responses
Braun, D., Caramalho, I., & Demengeot, J. (2002) · International Immunology · doi:10.1093/intimm/14.4.411 · Cited by 268
Lenschow, D. J., Giannakopoulos, N. V., Gunn, L. J., Johnston, C., O'Guin, A. K., Schmidt, R. E., Levine, B., & Virgin, H. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13974-13983.2005 · Cited by 268
The Role of Antibody Concentration and Avidity in Antiviral Protection
Bachmann, M. F., Kalinke, U., Althage, A., Freer, G., Burkhart, C., Roost, H.-P., Aguet, M., Hengartner, H., & Zinkernagel, R. M. (1997) · Science · doi:10.1126/science.276.5321.2024 · Cited by 267
Self-citationRequirement for STAT1 in LPS-induced gene expression in macrophages
Ohmori, Y., & Hamilton, T. A. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.4.598 · Cited by 267
Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis
Müller, U. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00021-0 · Cited by 266
Self-citationForero, A., Ozarkar, S., Li, H., Lee, C. H., Hemann, E. A., Nadjsombati, M. S., Hendricks, M. R., So, L., Green, R., Roy, C. N., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.07.007 · Cited by 265
Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators
Renauld, J.-C. (2003) · Nature Reviews Immunology · doi:10.1038/nri1153 · Cited by 265
Type I interferons: crucial participants in disease amplification in autoimmunity
Hall, J. C., & Rosen, A. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.237 · Cited by 265
To kill or to cure: options in host defense against viral infection
Guidotti, L. G., & Chisari, F. V. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80034-3 · Cited by 264
Microbiota-Induced Type I Interferons Instruct a Poised Basal State of Dendritic Cells
Schaupp, L., Muth, S., Rogell, L., Kofoed-Branzk, M., Melchior, F., Lienenklaus, S., Ganal-Vonarburg, S. C., Klein, M., Guendel, F., Hain, T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.022 · Cited by 263
Lambda Interferon Is the Predominant Interferon Induced by Influenza A Virus Infection In Vivo
Jewell, N. A., Cline, T., Mertz, S. E., Smirnov, S. V., Flaño, E., Schindler, C., Grieves, J. L., Durbin, R. K., Kotenko, S. V., & Durbin, J. E. (2010) · Journal of Virology · doi:10.1128/jvi.01703-09 · Cited by 263
Watanabe, T., Asano, N., Fichtner-Feigl, S., Gorelick, P. L., Tsuji, Y., Matsumoto, Y., Chiba, T., Fuss, I. J., Kitani, A., & Strober, W. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39481 · Cited by 262
Leonova, K. I., Brodsky, L., Lipchick, B., Pal, M., Novototskaya, L., Chenchik, A. A., Sen, G. C., Komarova, E. A., & Gudkov, A. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216922110 · Cited by 261
Sheehan, K. C. F., Lai, K. S., Dunn, G. P., Bruce, A. T., Diamond, M. S., Heutel, J. D., Dungo-Arthur, C., Carrero, J. A., White, J. M., Hertzog, P. J., et al. (2006) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.26.804 · Cited by 260
Cellular and Humoral Immunity against Vaccinia Virus Infection of Mice
Xu, R., Johnson, A. J., Liggitt, D., & Bevan, M. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6265 · Cited by 260
Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung
Chen, H. D., Fraire, A. E., Joris, I., Brehm, M. A., Welsh, R. M., & Selin, L. K. (2001) · Nature Immunology · doi:10.1038/ni727 · Cited by 259
Cytokines and immunity to viral infections
Ramshaw, I. A., Ramsay, A. J., Karupiah, G., Rolph, M. S., Mahalingam, S., & Ruby, J. C. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb01011.x · Cited by 257
Lim, J. Y. H., Gerber, S. A., Murphy, S. P., & Lord, E. M. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1506-7 · Cited by 257
STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS)
Messaoud-Nacer, Y., Culerier, E., Rose, S., Maillet, I., Rouxel, N., Briault, S., Ryffel, B., Quesniaux, V. F. J., & Togbe, D. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04664-5 · Cited by 256
McClary, H., Koch, R., Chisari, F. V., & Guidotti, L. G. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2255-2264.2000 · Cited by 255
Interferons and Their Stimulated Genes in the Tumor Microenvironment
Cheon, H., Borden, E. C., & Stark, G. R. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.02.002 · Cited by 255
STAT2 deficiency and susceptibility to viral illness in humans
Hambleton, S., Goodbourn, S., Young, D. F., Dickinson, P., Mohamad, S. M. B., Valappil, M., McGovern, N., Cant, A. J., Hackett, S. J., Ghazal, P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220098110 · Cited by 255
Lasfar, A., Lewis-Antes, A., Smirnov, S. V., Anantha, S., Abushahba, W., Tian, B., Reuhl, K., Dickensheets, H., Sheikh, F., Donnelly, R. P., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3653 · Cited by 254
The Type I Interferon Receptor: Structure, Function, and Evolution of a Family Business
Mogensen, K. E., Lewerenz, M., Reboul, J., Lutfalla, G., & Uzé, G. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313019 · Cited by 252
Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity
Hiller, B., Achleitner, M., Glage, S., Naumann, R., Behrendt, R., & Roers, A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120876 · Cited by 245
Scharton-Kersten, T., Contursi, C., Masumi, A., Sher, A., & Ozato, K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1523 · Cited by 217
Species-specific Regulation of Toll-like Receptor 3 Genes in Men and Mice
Heinz, S., Haehnel, V., Karaghiosoff, M., Schwarzfischer, L., Müller, M., Krause, S. W., & Rehli, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301476200 · Cited by 202
Systematic Discovery of TLR Signaling Components Delineates Viral-Sensing Circuits
Chevrier, N., Mertins, P., Artyomov, M. N., Shalek, A. K., Iannacone, M., Ciaccio, M. F., Gat-Viks, I., Tonti, E., DeGrace, M. M., Clauser, K. R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.10.022 · Cited by 179
Key role of T cell defects in age-related vulnerability to West Nile virus
Brien, J. D., Uhrlaub, J. L., Hirsch, A., Wiley, C. A., & Nikolich-Žugich, J. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090222 · Cited by 158
Impairment of T and B Cell Development by Treatment with a Type I Interferon
Lin, Q., Dong, C., & Cooper, M. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.79 · Cited by 163
Fehr, T., Schoedon, G., Odermatt, B., Holtschke, T., Schneemann, M., Bachmann, M. F., Mak, T. W., Horak, I., & Zinkernagel, R. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.921 · Cited by 162
Self-citationMajer, O., Bourgeois, C., Zwolanek, F., Lassnig, C., Kerjaschki, D., Mack, M., Müller, M., & Kuchler, K. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002811 · Cited by 156
T cell engagement of cross-presenting microglia protects the brain from a nasal virus infection
Moseman, E. A., Blanchard, A. C., Nayak, D., & McGavern, D. B. (2020) · Science Immunology · doi:10.1126/sciimmunol.abb1817 · Cited by 157
The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression
Reily, M. M., Pantoja, C., Hu, X., Chinenov, Y., & Rogatsky, I. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600919 · Cited by 149
Chhatbar, C., Detje, C. N., Grabski, E., Borst, K., Spanier, J., Ghita, L., Elliott, D. A., Jordão, M. J. C., Mueller, N., Sutton, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.003 · Cited by 141
Dual biological effects of the cytokines interleukin-10 and interferon-γ
Wilke, C. M., Wei, S., Wang, L., Kryczek, I., Kao, J., & Zou, W. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1104-5 · Cited by 138
Cilloniz, C., Pantin-Jackwood, M. J., Ni, C., Goodman, A. G., Peng, X., Proll, S. C., Carter, V. S., Rosenzweig, E. R., Szretter, K. J., Katz, J. M., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00553-10 · Cited by 136
“ground (27) were grown as monolayers in high-glucose Dulbecco’s modified”
MethodThe role of type I interferons in TLR responses
Noppert, S. J., Fitzgerald, K. A., & Hertzog, P. J. (2007) · Immunology & Cell Biology · doi:10.1038/sj.icb.7100099 · Cited by 135
Leschak, C. J., & Eisenberger, N. I. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000685 · Cited by 129
Barriga, F. M., Tsanov, K. M., Ho, Y.-J., Sohail, N., Zhang, A., Baslan, T., Wuest, A. N., Del Priore, I., Meškauskaitė, B., Livshits, G., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00443-5 · Cited by 125
ATF3 Is a Key Regulator of Macrophage IFN Responses
Labzin, L. I., Schmidt, S. V., Masters, S. L., Beyer, M., Krebs, W., Klee, K., Stahl, R., Lütjohann, D., Schultze, J. L., Latz, E., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500204 · Cited by 124
Hato, S. V., Ricour, C., Schulte, B. M., Lanke, K. H. W., de Bruijni, M., Zoll, J., Melchers, W. J. G., Michiels, T., & van Kuppeveld, F. J. M. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01006.x · Cited by 118
Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model
Wang, R., Yang, B., & Zhang, D. (2011) · Glia · doi:10.1002/glia.21167 · Cited by 115
Bourgeois, C., Majer, O., Frohner, I. E., Lesiak-Markowicz, I., Hildering, K.-S., Glaser, W., Stockinger, S., Decker, T., Akira, S., Müller, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002599 · Cited by 116
Innate Immune Sensing of Retroviral Infection via Toll-like Receptor 7 Occurs upon Viral Entry
Kane, M., Case, L. K., Wang, C., Yurkovetskiy, L., Dikiy, S., & Golovkina, T. V. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.011 · Cited by 93
Interferon-γ Acts Directly on Rejecting Renal Allografts to Prevent Graft Necrosis
Halloran, P. F., Afrouzian, M., Ramassar, V., Urmson, J., Zhu, L.-F., Helms, L. M. H., Solez, K., & Kneteman, N. M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63960-0 · Cited by 78
Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector.
Hensley, S. E., Cun, A. S., Giles-Davis, W., Li, Y., Xiang, Z., Lasaro, M. O., Williams, B. R. G., Silverman, R. H., & Ertl, H. C. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300024 · Cited by 78
Interfering with immunity: detrimental role of type I IFNs during infection
Stifter, S. A., & Feng, C. G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402794 · Cited by 78
Rao, T. N., Hansen, N., Stetka, J., Luque Paz, D., Kalmer, M., Hilfiker, J., Endele, M., Ahmed, N., Kubovcakova, L., Rybarikova, M., et al. (2021) · Blood · doi:10.1182/blood.2020005563 · Cited by 72
Ischemia/reperfusion induces interferon stimulated gene expression in microglia
McDonough, A., Lee, R. V., Noor, S., Lee, C., Le, T., Iorga, M., Phillips, J. L. H., Murphy, S., Möller, T., & Weinstein, J. R. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0725-17.2017 · Cited by 71
The wild-derived inbred mouse strain SPRET/Ei is resistant to LPS and defective in IFN-β production
Mahieu, T., Park, J. M., Revets, H., Pasche, B., Lengeling, A., Staelens, J., Wullaert, A., Vanlaere, I., Hochepied, T., van Roy, F., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510874103 · Cited by 70
Riedelberger, M., Penninger, P., Tscherner, M., Seifert, M., Jenull, S., Brunnhofer, C., Scheidl, B., Tsymala, I., Bourgeois, C., Petryshyn, A., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.01.023 · Cited by 64
Kuwata, T., Gongora, C., Kanno, Y., Sakaguchi, K., Tamura, T., Kanno, T., Basrur, V., Martinez, R., Appella, E., Golub, T., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7439-7448.2002 · Cited by 69
Kuchtey, J., Chefalo, P. J., Gray, R. C., Ramachandra, L., & Harding, C. V. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2244 · Cited by 66
MyD88 Signaling in B Cells Regulates the Production of Th1-dependent Antibodies to AAV
Sudres, M., Ciré, S., Vasseur, V., Brault, L., Da Rocha, S., Boisgérault, F., Le Bec, C., Gross, D. A., Blouin, V., Ryffel, B., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.101 · Cited by 59
Innate Immune Response Gene Expression Profiles of N9 Microglia Are Pathogen-Type Specific
McKimmie, C. S., Roy, D., Forster, T., & Fazakerley, J. K. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.012 · Cited by 51
Van Hoecke, L., Roose, K., Ballegeer, M., Zhong, Z., Sanders, N. N., De Koker, S., Saelens, X., & Van Lint, S. (2020) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2020.09.004 · Cited by 55
Molecular Pathogenicity of Enteroviruses Causing Neurological Disease
Majer, A., McGreevy, A., & Booth, T. F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00540 · Cited by 50
Gander-Bui, H. T. T., Schläfli, J., Baumgartner, J., Walthert, S., Genitsch, V., van Geest, G., Galván, J. A., Cardozo, C., Graham Martinez, C., Grans, M., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.023 · Cited by 47
The versatile plasmacytoid dendritic cell: Function, heterogeneity, and plasticity
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.10.002 · Cited by 35
Schmidt, H., Raasch, J., Merkler, D., Klinker, F., Krauss, S., Brück, W., & Prinz, M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.12.002 · Cited by 31
“IFNAR1−/− mice (Muller et al., 1994) were originally provided by U. Kalinke, Paul-Ehrlich Institute (PEI), Langen, Germany, and backcrossed 20 times to C57BL/6.”
Wegenka, U. M., Dikopoulos, N., Reimann, J., Adler, G., & Wahl, C. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.009 · Cited by 30
Deng, T., Feng, X., Liu, P., Yan, K., Chen, Y., & Han, D. (2013) · Immunology & Cell Biology · doi:10.1038/icb.2012.45 · Cited by 25
Riedelberger, M., Penninger, P., Tscherner, M., Hadriga, B., Brunnhofer, C., Jenull, S., Stoiber, A., Bourgeois, C., Petryshyn, A., Glaser, W., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101121 · Cited by 23
Milk Derived Peptides with Immune Stimulating Antiviral Properties
Sun, H., & Jensse, H. (2012) · Milk Protein · doi:10.5772/50158 · Cited by 12
Machida, M., Ambrozewicz, M. A., Breving, K., Wellman, L. L., Yang, L., Ciavarra, R. P., & Sanford, L. D. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.09.006 · Cited by 10
Metadata
- Authors
- Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M.
- Venue
- Science
- Published
- 1994-06-24
- Volume
- 264
- Issue
- 5167
- Pages
- 1918-1921
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2004829503
- Cited by
- 2,453
- References
- 27
- FWCI
- 18.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.